Genesis HealthCare (GEN) Reports In-Line Q3 EPS
Genesis HealthCare (NYSE: GEN) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.42 billion.
For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.
